title: Medical costs of CKD in the Medicare population.
abstract: Estimates of the medical costs associated with different stages of CKD are needed to assess the economic benefits of interventions that slow the progression of kidney disease. We combined laboratory data from the National Health and Nutrition Examination Survey with expenditure data from Medicare claims to estimate the Medicare program's annual costs that were attributable to CKD stage 1-4. The Medicare costs for persons who have stage 1 kidney disease were not significantly different from zero. Per person annual Medicare expenses attributable to CKD were $1700 for stage 2, $3500 for stage 3, and $12,700 for stage 4, adjusted to 2010 dollars. Our findings suggest that the medical costs attributable to CKD are substantial among Medicare beneficiaries, even during the early stages; moreover, costs increase as disease severity worsens. These cost estimates may facilitate the assessment of the net economic benefits of interventions that prevent or slow the progression of CKD.
authors.affiliation: Research Triangle International, Research Triangle Park, North Carolina, USA. honeycutt@rti.org
authors.forename: Amanda A
authors.initials: AA
authors.lastname: Honeycutt
authors.forename: Joel E
authors.initials: JE
authors.lastname: Segel
authors.forename: Xiaohui
authors.initials: X
authors.lastname: Zhuo
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Hoerger
authors.forename: Kumiko
authors.initials: K
authors.lastname: Imai
authors.forename: Desmond
authors.initials: D
authors.lastname: Williams
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018450:Disease Progression; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D006278:Medicare / Q000706:statistics & numerical data*; D009749:Nutrition Surveys; D015995:Prevalence; D051436:Renal Insufficiency, Chronic / Q000191:economics* / Q000453:epidemiology*; D012720:Severity of Illness Index; D014481:United States / Q000453:epidemiology
references.citation: JAMA. 2007 Nov 7;298(17):2038-47
references.pmid: 17986697
references.citation: MMWR Morb Mortal Wkly Rep. 2007 Mar 2;56(8):161-5
references.pmid: 17332726
references.citation: Health Serv Res. 2006 Apr;41(2):564-80
references.pmid: 16584465
references.citation: Diabetes Care. 2003 Aug;26(8):2300-4
references.pmid: 12882852
references.citation: Health Serv Res. 2009 Feb;44(1):303-20
references.pmid: 19146569
references.citation: Diabetes Care. 2008 Dec;31(12):2307-11
references.pmid: 19033416
references.citation: Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
references.pmid: 11904577
references.citation: J Health Econ. 2004 May;23(3):525-42
references.pmid: 15120469
references.citation: J Gen Intern Med. 2011 Apr;26(4):379-85
references.pmid: 20853156
references.citation: J Health Econ. 2001 Jul;20(4):461-94
references.pmid: 11469231
references.citation: Ann Intern Med. 2006 Aug 15;145(4):247-54
references.pmid: 16908915
references.citation: J Am Soc Nephrol. 2004 May;15(5):1300-6
references.pmid: 15100370